Enterprise Therapeutics' Grant

Enterprise Therapeutics raised a round of funding on April 05, 2017. Investors include Cystic Fibrosis Trust.

Enterprise Therapeutics is a UK-based biopharmaceutical company dedicated to the research and development of novel therapies for the treatment of respiratory diseases.…

Articles about Enterprise Therapeutics' Grant: